Karolinska Development AB ser. B (KDEV) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.004x

Based on the latest financial reports, Karolinska Development AB ser. B (KDEV) has a cash flow conversion efficiency ratio of -0.004x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-4.18 Million ≈ $-449.51K USD) by net assets (Skr1.10 Billion ≈ $118.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See KDEV defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Karolinska Development AB ser. B - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Karolinska Development AB ser. B's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Karolinska Development AB ser. B Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Karolinska Development AB ser. B ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Touchstone Exploration Inc TO:TXP	0.068x
Enra Group Bhd KLSE:8613	-0.008x
Camellia Metal Co Ltd TWO:2064	0.107x
HyosungONBCo.Ltd KQ:097870	-0.021x
AJ Bell plc LSE:AJB	0.252x
IT Link PA:ALITL	0.065x
K2A Knaust & Andersson Fastigheter AB (publ) ST:K2A-B	-0.007x
Chin Yang Chem KO:051630	0.009x

Annual Cash Flow Conversion Efficiency for Karolinska Development AB ser. B (2008–2025)

The table below shows the annual cash flow conversion efficiency of Karolinska Development AB ser. B from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Karolinska Development AB ser. B.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr1.04 Billion ≈ $112.44 Million	Skr-26.06 Million ≈ $-2.80 Million	-0.025x	-11.01%
2024-12-31	Skr1.24 Billion ≈ $133.31 Million	Skr-27.83 Million ≈ $-2.99 Million	-0.022x	-11.95%
2023-12-31	Skr1.25 Billion ≈ $134.18 Million	Skr-25.02 Million ≈ $-2.69 Million	-0.020x	+23.42%
2022-12-31	Skr1.24 Billion ≈ $133.60 Million	Skr-32.53 Million ≈ $-3.50 Million	-0.026x	-252.38%
2021-12-31	Skr971.09 Million ≈ $104.50 Million	Skr16.70 Million ≈ $1.80 Million	0.017x	+141.46%
2020-12-31	Skr800.27 Million ≈ $86.12 Million	Skr-33.20 Million ≈ $-3.57 Million	-0.041x	-464.27%
2019-12-31	Skr1.01 Billion ≈ $108.45 Million	Skr-7.41 Million ≈ $-797.33K	-0.007x	-116.54%
2018-12-31	Skr296.01 Million ≈ $31.86 Million	Skr13.15 Million ≈ $1.42 Million	0.044x	+4.76%
2017-12-31	Skr267.12 Million ≈ $28.75 Million	Skr11.33 Million ≈ $1.22 Million	0.042x	+114.06%
2016-12-31	Skr29.82 Million ≈ $3.21 Million	Skr-8.99 Million ≈ $-967.90K	-0.302x	+76.99%
2015-12-31	Skr247.88 Million ≈ $26.68 Million	Skr-325.02 Million ≈ $-34.98 Million	-1.311x	-1890.69%
2014-12-31	Skr1.65 Billion ≈ $177.09 Million	Skr-108.39 Million ≈ $-11.66 Million	-0.066x	-50.19%
2013-12-31	Skr1.87 Billion ≈ $201.28 Million	Skr-82.03 Million ≈ $-8.83 Million	-0.044x	+41.84%
2012-12-31	Skr2.02 Billion ≈ $217.84 Million	Skr-152.65 Million ≈ $-16.43 Million	-0.075x	-22.86%
2011-12-31	Skr2.17 Billion ≈ $233.95 Million	Skr-133.44 Million ≈ $-14.36 Million	-0.061x	-8.30%
2010-12-31	Skr1.72 Billion ≈ $184.80 Million	Skr-97.32 Million ≈ $-10.47 Million	-0.057x	-231.51%
2009-12-31	Skr2.00 Billion ≈ $215.05 Million	Skr-34.16 Million ≈ $-3.68 Million	-0.017x	-56.75%
2008-12-31	Skr1.65 Billion ≈ $177.66 Million	Skr-18.00 Million ≈ $-1.94 Million	-0.011x	--

About Karolinska Development AB ser. B

ST:KDEV Sweden Biotechnology

Market Cap

$29.36 Million

Skr272.85 Million SEK

Market Cap Rank

#23886 Global

#465 in Sweden

Share Price

Skr0.29

Change (1 day)

+0.00%

52-Week Range

Skr0.25 - Skr1.08

All Time High

Skr10.82